Products

VU0359595 | 857371

(1R,2R)-N-([S]-1-{4-[5-bromo-2-oxo-2,3-dihydro-1H-benzo(d)imidazol-1-yl]piperidin-1-yl}propan-2-yl)-2-phenylcyclopropanecarboxamide

857371P

Powder

857371P-
1mg
$137.00

All Prices in US Dollars
Quantity discounts may be available at the 5 and 10 count level.
Contact customer service for a quote.
Add your chosen unit to the shopping cart and adjust the quantity to see the discount.


To purchase larger quantities of this product please contact our Customer Service Department

  • Product
  • Data
  • Downloads
  • Reference
VU0359595 has been shown to selectively inhibit the PLD1 isoform at nM levels (see data below).
 
Molecular Formula
C25H29BrN4O2
Percent Composition
C 60.36%, H 5.88%, Br 16.06%, N 11.26%, O 6.43%
Purity
>99%
Stability
1 Years
Storage
-20°C
CAS Number
1246303-14-9
CAS Registry Number is a Registered Trademark of the American Chemical Society
Molecular Weight
497.427
Exact Mass
496.147
Synonyms
EVJ
VU0359595
Download
Notes
GIF Graphics File. 
GIF Graphics File. 
MDL Molfile. 
CDX File. 
Bruntz, R.C., H.E. Taylor, C.W. Lindsley, and H.A. Brown. (2013). Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cells. J Biol Chem [PubMed]Lewis, J.A., Scott, S.A., Lavieri, R., Buck, J.R., Selvy, P.E., Stoops, S.L., Armstrong, M.D., Brown, H.A., and C.W. Lindsley. (2009) Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I. Impact of alternative halogenated privileged structures for PLD1 specificity. Bioorganic and Medicinal Chemistry Letters. 19, 1916-1920. [PubMed]